improve diagnostic accuracy by supplementing PSA testing. These biomarkers include derivatives of PSA, such as PSA density and velocity, and newer molecular forms, such as (-2) pro-PSA. Other significant biomarkers include the Prostate health index (PHI), the 4K score, prostate cancer antigen 3 ...